Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 16
- Q1 2024, +6 vs. previous quarter
- 13F value
- $34.9M
- Reported value at the end of Q1 2024
- Superinvestors holding
- 0
- At the end of Q1 2024
Superinvestors holding LABP, Q1 2024
No superinvestor reported holding LABP at the end of Q1 2024.
Latest insider trades
Open-market purchases and sales by Landos Biopharma, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 (view filing) | Feb 28 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −5.72M | – | – | −100.0%0 after | 5 lots |
| Jan 11, 2023 (view filing)6:45 PM ET | Jan 10 | 1 day | Edelman Joseph and 4 others10% Owner | PPurchase | +30.9M | $0.54 | +$16.7M | –3.64M after | Derivative2 lots |
| Sep 27, 2022 (view filing)4:30 PM ET | Sep 23 | 4 days | RTW Investments, LP and 1 other10% Owner | SSale | −300.0K | $0.69 | −$207.0K | −7.0%3.98M after | |
| Dec 20, 2021 (view filing) | Dec 16-20 | 4 days | Bassaganya-Riera Josep10% Owner | SSale | −93.5K | $4.88 | −$456.1K | −1.8%4.99M after | 3 lots |
| Dec 15, 2021 (view filing) | Dec 13-15 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −125.0K | $5.16 | −$644.9K | −2.4%5.15M after | 3 lots |
| Dec 10, 2021 (view filing) | Dec 9-10 | 1 day | Bassaganya-Riera Josep10% Owner | SSale | −51.2K | $5.88 | −$300.7K | −1.0%5.27M after | 2 lots |
| Dec 8, 2021 (view filing) | Dec 6-8 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −103.5K | $6.45 | −$668.3K | −1.9%5.32M after | 3 lots |
| Dec 3, 2021 (view filing) | Dec 1-3 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −98.1K | $6.52 | −$640.0K | −1.3%7.30M after | 3 lots |
| Dec 1, 2021 (view filing) | Nov 29-30 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −50.4K | $7.22 | −$364.1K | −0.7%7.39M after | 2 lots |
Top 10 13F holders, Q1 2024
The largest institutional positions in Landos Biopharma, Inc. at the end of Q1 2024; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 1,486,991 | $31.9M | 0.56% | 00.0% | Unchanged |
| Deltec Asset Management LLC | 50,000 | $1.07M | 0.21% | +50,000 | New |
| Renaissance Technologies LLC | 18,890 | $406.0K | 0.00% | +7,630+67.8% | Added |
| Macquarie Group Ltd | 14,718 | $316.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 14,537 | $313.0K | 0.02% | +14,537 | New |
| Geode Capital Management, LLC | 12,604 | $271.0K | 0.00% | 00.0% | Unchanged |
| PenderFund Capital Management Ltd. | 9,300 | $270.8K | 0.07% | +9,300 | New |
| Black Maple Capital Management LP | 10,405 | $223.5K | 0.15% | +10,405 | New |
| UBS Group AG | 4,084 | $87.7K | 0.00% | +4,042+9,623.8% | Added |
| Tower Research Capital LLC (TRC) | 896 | $19.2K | 0.00% | +896 | New |